Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042081 · ClinicalTrials.gov registry record · Phase 3
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
A Phase 3 study, sponsored by Anesiva.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,000
- Enrollment target
NCT00042081: Completed Phase 3 study, sponsored by Anesiva.
NCT00042081 is a Phase 3 study that has completed, run by Anesiva. The registered enrollment target is 3,000 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (289% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00042081, a Phase 3 study, has completed, sponsored by Anesiva.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of graft pretreatment with CGT003 (E2F Duplex Decoy), as compared to placebo, on the incidence of patients experiencing vein graft failure after coronary artery bypass surgery.
Interventions
- DRUG CGT003 (E2F Duplex Decoy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2002-07 |
| Est. Completion | 2005-02 |
| Phase | Phase 3 |
What the finished NCT00042081 record still lists
NCT00042081 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (289% higher).
The record links to 0 conditions, and to 1 intervention - of which CGT003 (E2F Duplex Decoy) is the first listed.
NCT00042081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00042081 about?
NCT00042081 is a clinical study titled "Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures". The purpose of this study is to determine the efficacy of graft pretreatment with CGT003 (E2F Duplex Decoy), as compared to placebo, on the incidence of patients experiencing vein graft failure after coronary artery bypass surgery.
What is the current status of trial NCT00042081?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,000 participants. The study started on 2002-07. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00042081?
The interventions under investigation include: CGT003 (E2F Duplex Decoy) (DRUG).
Who is sponsoring clinical trial NCT00042081?
This trial is sponsored by Anesiva, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00042081's enrollment target sits among peer trials
3,000 79th of 2000 higher than 1,921 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia